minoryx.com
HOME - Minoryx TherapeuticsMinoryx is a clinical stage biotech company leading the development of new therapies for X-ALD and other Inborn Errors of Metabolism.
http://www.minoryx.com/
Minoryx is a clinical stage biotech company leading the development of new therapies for X-ALD and other Inborn Errors of Metabolism.
http://www.minoryx.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Sunday
LOAD TIME
1.6 seconds
16x16
32x32
64x64
MINORYX THERAPEUTICS S.L.
Marc Martinell
Av. Er●●●●●●uch 32
Ma●●ro , B, 08302
SPAIN
View this contact
MINORYX THERAPEUTICS S.L.
Marc Martinell
Av. Er●●●●●●uch 32
Ma●●ro , B, 08302
SPAIN
View this contact
1&1 Internet Espana S.L.U.
Hostmaster ONEANDONE
Calle N●●●●●●●erra 14
Ma●●id , M, 28007
SPAIN
View this contact
BUY YOUR DOMAIN
12
YEARS
8
MONTHS
3
DAYS
1 & 1 INTERNET AG
WHOIS : whois.schlund.info
REFERRED : http://1and1.com
PAGES IN
THIS WEBSITE
17
SSL
EXTERNAL LINKS
20
SITE IP
217.160.230.6
LOAD TIME
1.61 sec
SCORE
6.2
HOME - Minoryx Therapeutics | minoryx.com Reviews
https://minoryx.com
Minoryx is a clinical stage biotech company leading the development of new therapies for X-ALD and other Inborn Errors of Metabolism.
minoryx.com
Minoryx raises 1.6M€ in a round led by Caixa Capital Risc | Minoryx
http://www.minoryx.com/minoryx-raises-1-6me-in-a-round-led-by-caixa-capital-risc
GM1 gangliosidosis and Morquio B. Minoryx raises 1.6M in a round led by Caixa Capital Risc. These funds will allow moving into clinical trials Minoryx’s candidate for X-linked Adrenoleukodystrophy, and further develop its platform for identifying non-competitive pharmacological chaperones. la Caixa is leading this operation through the Caixa Innvierte BioMed II fund, joined by the Sanfilippo Foundation Switzerland. Laquo; Previous post. Next Post ». Minoryx receives Innovative SME certificate.
GM1 gangliosidosis and Morquio B | Minoryx
http://www.minoryx.com/pipeline/gm1-gangliosidosis
GM1 gangliosidosis and Morquio B. GM1 gangliosidosis and Morquio B. GM1-gangliosidosis is a rare and severe Lysosomal Storage Disorder (LSD). This genetic disease is mainly characterized by a severe neurological damage and currently there is no treatment. 8211; Type III GM, although is also known as adult form, affects children and young adults with a variable onset between 3 and 30 years. This form is mostly characterized by cerebral dysfunction, dystonia, short stature and mild vertebral deformities.
Meet us at Bio€quity 2015 | Minoryx
http://www.minoryx.com/meet-us-at-bioequity-2015
GM1 gangliosidosis and Morquio B. Meet us at Bio quity 2015. May 19th and 20th. Laquo; Previous post. Next Post ». Minoryx Therapeutics Initiates Phase 1 clinical trial of MIN-102. MIN-102, a differentiated PPAR agonist, targets X-linked Adrenoleukodystrophy (X-ALD), a life threatening orphan CNS disease. Minoryx Therapeutics appoints Dr. Uwe Meya as Chief Medical Officer. Mataró, Barcelona, Spain, June 14, 2016 Minoryx Therapeutics, a drug development company specialized in. Privacy and Cookies Policy.
Funding | Minoryx
http://www.minoryx.com/english-about-minoryx/funding
GM1 gangliosidosis and Morquio B. TecnoCampus Mataró-Maresme, TCM3 Av. Ernest Lluch 32 08302 Mataró (Barcelona) Spain T. 34 93 544 14 66 info@minoryx.com. This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept. Privacy and Cookies Policy.
Pipeline | Minoryx
http://www.minoryx.com/pipeline
GM1 gangliosidosis and Morquio B. The company’s leading program is a differentiated PPAR gamma agonist (MIN-102) being developed for X-ALD and currently in phase 1. Minoryx is also working on a new class of compounds, non-competitive pharmacological chaperones, identified through its innovative proprietary platform – SEE-Tx. X linked adrenoleukodystrophy (X-ALD) is a rare inherited peroxisomal neurodegenerative disorder, often fatal disease. The disease is caused by inactivation of the peroxisomal ABCD1 ...
TOTAL PAGES IN THIS WEBSITE
17
Trokola Factory » Web
http://trokola.com/projectes/web
Call us toll free: 938648602. Top notch Multipurpose WordPress Theme! Call us toll free: 938648602. La Teta Menjar and Beure. Projecte web corporativa bar La Teta. Palau-solità i Plegamans. 2011. Parc de Reserca UAB. Projecte de redisseny web del Parc de Reserca UAB. Bellaterra 2011. Projecte web corporativa Garden Palau. Palau-solità i Plegamans. 2008. Projecte web corporativa Benet Autoescoles. Palau-solità i Plegamans 2009. Projecte web Cristalplat. Sentmenat 2013.
Casos d'èxit - Informe Biocat 2015
http://informe.biocat.cat/casos-exit
Dummy text, dummy text, dummy text. Cap a un lloc de primer nivell en un món competitiu. Tendències globals. Reptes locals. Xifres i dades clau. La BioRegió: El sector català de les ciències de la vida i de la salut. Situació i anàlisi. Empreses – Dades globals. Empreses Anàlisis per subsectors. Entitats de recerca i infraestructures de suport. El futur de la salut i de la indústria farmacèutica. Repensant les ciències de la vida: l’emergència de les biofarmes. Quina innovació aporteu al mercat? Des de l...
Claus per Bioemprendre (en temps de crisi) - Tercer Curs de Bioemprenedoria per a estudiants, llicenciats i investigadors en ciències de la vida i biomedicina
http://www.bioemprenedors.org/programa.htm
Descarregar el programa del curs en pdf. Presentació i Moderació de les sessions: Jordi Naval - Emprenedor en Life Sciences and Education Changemaker. Primera sessió: Dimarts 5 de Maig, de 18:30 a 20:30 h. LA BIOEMPRENEDORIA ÉS ESSENCIAL PER AL DESENVOLUPAMENT DE LA BIOTECNOLOGIA". Invertir en early stage: quan una oportunitat és interessant. Josep-Lluís Sanfeliu, General Partner de YSIOS CAPITAL . Les bones idees hi són: només cal trobar-les. Lluís Ruíz, Fundador i Director de SPHERIUM BIOMED. Ara que n...
healthequity
http://www.healthequity.es/index.html
A través de la innovación. Healthequity es una sociedad de capital riesgo especializada en proyectos early-stage del sector salud: dispositivos médicos, biotecnología y servicios sanitarios. Es un fondo promovido por el Colegio Oficial de Médicos de Barcelona y el grupo financiero Riva y Garcia que está buscando proyectos para realizar sus primeras inversiones. Healthequity fue registrado en la CNMV y fundado en el año 2012. Fondo financiado por FEDER. El objetivo de Healthequity es diversificar riesgos,...
L’atractiu de la BioRegió de Catalunya per a la inversió estrangera - Informe Biocat 2015
http://informe.biocat.cat/atractiu-de-la-bioregio-de-catalunya-per-a-la-inversio-estrangera
Dummy text, dummy text, dummy text. Cap a un lloc de primer nivell en un món competitiu. Tendències globals. Reptes locals. Xifres i dades clau. La BioRegió: El sector català de les ciències de la vida i de la salut. Situació i anàlisi. Empreses – Dades globals. Empreses Anàlisis per subsectors. Entitats de recerca i infraestructures de suport. El futur de la salut i de la indústria farmacèutica. Repensant les ciències de la vida: l’emergència de les biofarmes. Com es pot canviar aquesta situació? Més co...
Informe Biocat 2015 | BIOBIZNEWS
https://biobiznews.net/2016/05/20/informe-biocat-2015
Reconec que parlant de l’. No sóc equànime, perquè he estat part de l’equip gestor dels continguts i, per tant, estic segura que aporta la millor informació disponible sobre el sector de les ciències de la vida a Catalunya. En concret, he estat la autora del capítol. La BioRegió: El sector català de les ciències de la vida i de la salut. Situació i anàlisi. A partir de les dades que de forma sistemàtica i rigurosa recull l’equip de Gestió del Coneixement de Biocat. O com és l’. 75 en el període 2013-2015.
---- healthequity ----
http://www.healthequity.es/index_eng.html
Healthequity is a VC fund focused on investing in early-stage companies in the Healthcare sector: Biotechnology, medical devices and healthcare services. Promoted by the Medical Association of Barcelona and the financial group Riva y Garcia, HealthEquity is looking for projects to make its first investments. Healthequity was registered with the CNMV and founded in 2012. Fund financed by FEDER. The aim is to diversify risk, making companies coexist in different stages of maturation and in different sub-se...
TOTAL LINKS TO THIS WEBSITE
20
Minor Yankee Blog
Monday, January 24, 2005. The top 25 should debut the week of Feb. 1st on the RLYW and it will begin at number 25 and end with the number 1 prospect. Thanks for being patient. * * Questions, comments, suggestions to minoryankeeblog@hotmail.com. Para; 7:02 PM. Sunday, December 19, 2004. I have a new post up at the RLYW, it can be found right here. Questions, comments, suggestions to minoryankeeblog@hotmail.com. Para; 5:58 PM. Wednesday, November 10, 2004. Please excuse any typos, I am crunched for time).
Ludwig und der Rest der Welt
Ludwig und der Rest der Welt. Wir trennen unseren Müll. 12 April 2010 @ 23:05. Das Versagen der Mino. Heute war nicht mein Küchentag. Achtung. Reines Küchengejammer. Ich habe versucht Japanischen Pudding zu machen. Zuerst hab ich die Karamellsoße gemacht. Aber ich hab sie zu schnell erhitzt und deshalb wurde sie zu dunkel und hat nach Rauch geschmeckt. Dann hab ich sie in Gläser gefüllt. Dann kam meine Mutter und sagte, dass man in diesen Gläsern nicht backen kann. Altes Karamell war zu wenig. So dürfte ...
Minor Yet Major - Celebrating Diversity - Minor Yet MajorMinor Yet Major | We were born to stand out!
We believe our urban children lack engagement in cultural diversity. This lack of cultural competence can inhibit a child’s ability to communicate and effectively interact with various cultures as they grow into adulthood. Cultural competence and unity should be an ongoing learning and reflective practice and one way to combat this is through providing creative outlets in youth development, the arts, community involvement for the youth. Group Photo from Children’s Diversity Event.
minoryn (Odet) - DeviantArt
Window.devicePixelRatio*screen.width 'x' window.devicePixelRatio*screen.height) :(screen.width 'x' screen.height) ; this.removeAttribute('onclick')" class="mi". Window.devicePixelRatio*screen.width 'x' window.devicePixelRatio*screen.height) :(screen.width 'x' screen.height) ; this.removeAttribute('onclick')". Join DeviantArt for FREE. Forgot Password or Username? Deviant for 1 Year. This deviant's full pageview. Last Visit: 65 weeks ago. This is the place where you can personalize your profile!
portfolio
2D and 3D design. 2D and 3D design. All the images used in this template are the property of Vasuma. And used with permission. Vancouver, BC, Canada.
HOME - Minoryx Therapeutics
COMMITTED TO FIGHTING LIFE-THREATENING RARE DISEASES. TOWARDS A PHARMACOLOGICAL THERAPY FOR ADRENOLEUKODYSTROPHY. NEW HOPE FOR PEOPLE SUFFERING FROM NEURODEGENERATIVE DISEASES. Minoryx focuses its research on orphan CNS diseases, a large group of rare diseases affecting the central nervous system. A rare inherited peroxisomal neurodegenerative disorder, chronically debilitating and life-threatening. TecnoCampus Mataró-Maresme, TCM3 Av. Ernest Lluch 32 08302 Mataró (Barcelona) Spain. T 34 93 544 14 66.
Blog de minos--10 - Aminöù Miinöù Algerianö - Skyrock.com
Mot de passe :. J'ai oublié mon mot de passe. Ž /'.'/Ž .` ž. 039;/ ./.: .š. 039;(Ž.Ž. /'./. 039; '. . . Ž. Vous I ♥ Me ♥. I ♥ IMANE ♥. 9829;█▀▀ █▀█ █▀█ █♥. 9829;█▄▄ █▄█ █▄█ █▄▄▆♥. 8226;¸.•´. 184;•´♥♥♥. Mise à jour :. YAK ANA NABGHIHA (HAKIM SALHI). Abonne-toi à mon blog! N'oublie pas que les propos injurieux, racistes, etc. sont interdits par les conditions générales d'utilisation de Skyrock et que tu peux être identifié par ton adresse internet (54.145.69.42) si quelqu'un porte plainte. Ou poster avec :.
Minos-23 (Minos) | DeviantArt
Window.devicePixelRatio*screen.width 'x' window.devicePixelRatio*screen.height) :(screen.width 'x' screen.height) ; this.removeAttribute('onclick')". Deviant for 6 Years. This deviant's activity is hidden. Deviant since Jul 10, 2011. This is the place where you can personalize your profile! By moving, adding and personalizing widgets. You can drag and drop to rearrange. You can edit widgets to customize them. The bottom has widgets you can add! Some widgets you can only access when you get Core Membership.
Blog de Minos-48 - ▐▬▌℮ ll o w 3 - Skyrock.com
Mot de passe :. J'ai oublié mon mot de passe. 9616;▬▌℮ ll o w 3. 1O coms chez toi Si Tu m'AJoute moi a tes favoris. 8226; Stαtut : Jsuii Laa x). 8226; Infσrறαtiσns :. 8250; Blα : Blα . 8250; Cσறs : R℮ndus . 8250; Pubs : Acc℮pt℮℮ . 8250; Chiffr℮s : Refus℮℮ . 8250; Aறis : Acc℮pt℮℮ . 8250; Fαvσris : C℮ux Qu℮ J'Aiற℮℮ . 9835; Rap and Rn'b U.S. ♫. 9835; Rap and Rn'b U.S. ♫. 9835; Rap and Rn'b U.S. ♫. 9835; Rap and Rn'b U.S. ♫. Té d'la Police où Qùoi! Mise à jour :. Abonne-toi à mon blog! Poster sur mon blog.
Blog de Minos-491 - Blog de Minos-491 - Skyrock.com
Mot de passe :. J'ai oublié mon mot de passe. Coucou je suis nouveau et je veut plein de com's dans mon blog mdr. Mise à jour :. Moi Que Tu Est Née : Janvier : Je suis. Consignes: ♦ Fais des missions et Gagne tes c. Consigne: Choisi un numéro et mets un comment. Jet Privé Pour Le Jet Privé, tu dois. Abonne-toi à mon blog! L'auteur de ce blog n'accepte que les commentaires de ses amis. Tu n'es pas identifié. Clique ici pour poster un commentaire en étant identifié avec ton compte Skyrock. Posté le samedi ...
Blog de MINOS-66 - Blog de MINOS-66 - Skyrock.com
Mot de passe :. J'ai oublié mon mot de passe. JE SOUI GITANE EEE JAIME DES COM ALOR METE MOI DES COM MES PAS DES MOVE OU VOU CONESE LA SOUIT OKKKKKKKKKKKK. Mise à jour :. Abonne-toi à mon blog! N'oublie pas que les propos injurieux, racistes, etc. sont interdits par les conditions générales d'utilisation de Skyrock et que tu peux être identifié par ton adresse internet (54.145.69.42) si quelqu'un porte plainte. Ou poster avec :. Posté le mardi 28 août 2012 09:09. Ou poster avec :. Ou poster avec :. Ma ch...
